Welcome to Peptide Card of AntiTbPdb
| This page displays user query in tabular form. |
KKVVFKVKFK details |
| Primary information | |
|---|---|
| ID | antitb_1353, |
| Name | 9756752 |
| N-Terminal modification | Peptide KSl |
| C-Terminal Modification | KKVVFKVKFK |
| Chemical Modification | Free |
| Linear/Cyclic | Free |
| Length | None |
| Chirality | Linear |
| Nature | 10 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC 607 |
| Cell Line | MIC = 6.25μg/ml |
| Inhibition Concentration | In vitro |
| Sequence | 1998 |
| Cytotoxicity | Mouse erythrocyte |
| In vivo Model | NA |
| Lethal Dose | None |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | antifungal, antibacterial against C.albicans |
| Tertiary Structure (Technique) | Not Predicted), |
| Primary information | |
|---|---|
| ID | antitb_1974, |
| Name | 9756752 |
| N-Terminal modification | KSL |
| C-Terminal Modification | KKVVFKVKFK |
| Chemical Modification | Free |
| Linear/Cyclic | Amidation |
| Length | None |
| Chirality | Linear |
| Nature | 10 |
| Source | L |
| Origin | Cationic |
| Species | Synthetic |
| Inhibition Concentration | Mycobacterium smegmatis |
| In Vitro/ In vivo | Mycobacterium smegmatis ATCC 607 |
| Cell Line | MIC=6.25µg/ml |
| Inhibition Concentration | In vitro |
| Sequence | 1998 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | cell wall |
| PMID | NA |
| Year of Publication | Candida albicans, Shigella flexneri, Proteus vulgaris, Pseudomonas aeruginosa, Escherichia coli, Micrococcus luteus, Staphylococcus epidermidis, MRSA, Staphylococcus aureus |
| Tertiary Structure (Technique) | Not Predicted), |